Stay updated on KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.

Latest updates to the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no study data or core content appears to be altered.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedNew study locations across Alabama, Arizona, Arkansas, California, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Minnesota, Missouri, Nevada, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, and West Virginia were added (v3.3.3). Entries removed include the previous state locations (v3.3.2) and the HHS Vulnerability Disclosure link.SummaryDifference2%

- Check49 days agoChange DetectedRevision: v3.3.2 is displayed, replacing the previous v3.3.1. This appears to be a minor internal update with no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange Detected- Revision updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check64 days agoChange DetectedRemoved the government funding lapse notice that warned about potential updates and NIH operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check78 days agoChange DetectedThe two screenshots depict the same study details page with identical sections and data; any observed differences are minor and non-substantive. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.